
Wednesday, January 06, 2021 7:50:35 AM
LET'S ALL MAKE SOME $$$$$$$
Recent AMRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 01:21:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 12:33:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 12:31:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 12:12:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 12:11:32 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2025 10:02:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2025 09:57:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 11:58:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2025 11:13:08 AM
- Amneal Reports Fourth Quarter and Full Year 2024 Financial Results • Business Wire • 02/28/2025 11:00:00 AM
- Amneal Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide • Business Wire • 02/19/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2025 09:31:45 PM
- Amneal to Report Fourth Quarter and Full Year 2024 Results on February 28, 2025 • Business Wire • 01/29/2025 01:30:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/23/2025 10:49:13 PM
- Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin • Business Wire • 01/23/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2025 11:14:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2025 09:25:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2025 09:22:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/02/2025 09:48:19 PM
- Amneal to Participate at Upcoming Investor Conferences • Business Wire • 12/04/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/26/2024 09:41:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/25/2024 09:26:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2024 09:38:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/22/2024 03:39:32 PM
- Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist • Business Wire • 11/21/2024 09:05:00 PM
One World Products' Isiah Thomas Issues Investor Update • OWPC • Mar 6, 2025 9:19 AM
Authentic Holdings To Reduce Debt by over $2 Million While Achieving Substantial Revenue Growth • AHRO • Mar 6, 2025 8:00 AM
Nightfood Holdings, Inc. (NGTF) Signs Letter of Intent to Acquire Skytech Automated Solutions Inc. to Expand AI-Powered Robotics Portfolio • NGTF • Mar 5, 2025 8:44 AM
North Bay Resources Announces Refinery Shipment of Gold Concentrate from Bishop Gold Mill • NBRI • Mar 4, 2025 9:00 AM
UAV Corp. Secures LOI for Multi-Unit Purchase of DART 600 Airship Systems • UMAV • Mar 4, 2025 8:30 AM
UCASU Expected to Report $0.02/share Net Profit for 2024 • UCASU • Mar 3, 2025 1:55 PM